Background Alveolar macrophages from patients with sarcoidosis express increased quantities of HLA-DR during activation. Because silver staining has been described as a sensitive indicator of cellular activity a study was performed to examine whether it relates to HLA-DR antigen expression.
Silver staining of nucleoli was first reported in 1899.' A local and functional relation was found between certain chromosomes and nucleoli;2 the regions thus identified have been called nucleolar organiser regions (NORs).34 These are regions of acrocentric chromosomes containing major ribosomal RNA (rRNA) genes and NOR associated proteins, which result from transcription 8 and can be seen with silver staining. Previous studies have related the amount and distribution of NOR associated silver stained proteins with cellular activity in vitro"'3 and in vivo.'"'6 The silver stained dots are usually called AgNORs, and should not be confused with the number of transcriptionally active NORs in the cell. Wide discrepancies have been observed between the number of silver stained dots and the number of NOR chromosome genomes. "' 8 In many studies silver staining has been found to be helpful in the diagnosis of malignancy and as a sensitive indicator of cellular activity. 6 19 21 Alveolar macrophages in patients with sarcoidosis are described as being highly activated and are concerned in an active immunological process. [22] [23] [24] [25] [26] They have been shown to express increased quantities of HLA-DR antigen during activation. The fact that silver staining is also a sensitive marker of cellular activation prompts the question of whether silver staining is correlated with HLA-DR expression, an immunological feature of activated alveolar macrophages. The object of our investigation was to compare silver staining and HLA-DR expression in alveolar macrophages obtained by bronchoalveolar lavage from patients with sarcoidosis and from healthy control subjects.
Methods

SUBJECTS
We studied 11 patients with pulmonary sarcoidosis (confirmed by transbronchial lung biopsy) and 11 healthy control subjects. Consecutive patients with sarcoidosis seen in the pulmonary unit were included provided that they had not been treated and were nonsmokers at the time of the investigation; two patients were ex-smokers who had smoked less than 10 cigarettes a day and stopped at least two years before the investigation. The control subjects were healthy non-smokers, three of whom had smoked less than 10 cigarettes a day but had stopped at least three years before the investigation. The diagnosis of sarcoidosis was confirmed by transbronchial lung biopsy.
BRONCHOALVEOLAR LAVAGE
All subjects underwent bronchoalveolar lavage,27 which was performed with a fibreoptic bronchoscope (Olympus B10) after local anaesthesia with 2% xylocaine. One hundred millilitres of isotonic warmed saline were instilled into the middle lobe in 20 ml aliquots and recovered by gentle aspiration. The fluid was collected into siliconised glass tubes and processed immediately at 4°C.
HLA-DR ANALYSIS
Cells were counted in a haemocytometer. Cytocentrifuge cell preparations were made for May-Grunwald-Giemsa and silver staining. Differential cell counts were performed on 400 cells and individual counts were given as per-Correlation of morphological patterns of nucleoli in alveolar macrophages with HLA-DR antigen expression in sarcoidosis 
